Oncology Central

Maintenance treatment for metastatic colorectal cancer


Metastatic colorectal cancer is now commonly treated with doublet chemotherapy plus targeted chemotherapy and initially was used until progression or development of unacceptable toxicities. However, even in responding patients it is difficult to continue the treatment for more than 4–6 months due to toxicities, such as neutropenia, sensory neuropathy and asthenia or hand and foot syndrome.

To view restricted content, please:

Leave A Comment

Please wait...

Would you like access to more immuno-oncology content?

Register with Oncology Central to find out the latest news, opinions and journal articles published in the oncology field by leading experts.